RecruitingNot ApplicableNCT05926713

Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

Evaluate the Effect of Dietary Supplement Combined Supervised Exercise on Physical Performance and Body Composition Among Patients With Sarcopenia and Severe Sarcopenia Comorbid With COPD or ILD: A Prospective, Multi-center Cohort Study


Sponsor

Orient Europharma Co., Ltd.

Enrollment

100 participants

Start Date

Mar 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This trial is a prospective multi-center study. The purpose of this study is to evaluate the effect of dietary supplement combined with supervised exercised on the physical performance, body composition and lung function among patients with Sarcopenia and severe Sarcopenia in chronic lung disease. After participants enroll in this study, 12-week clinical trial will be conducted to analyze the improvement regarding Sarcopenia and different severity of Sarcopenia before and after the intervention of exercise and nutritional products, which can further provide reference for clinical intervention and rehabilitation.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study looks at whether combining a dietary supplement with exercise can improve muscle strength and function in people with lung disease (COPD or interstitial lung disease) who also have sarcopenia — a condition where muscles become weak and shrink with age. **You may be eligible if...** - You are an outpatient with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) and your doctor says you don't need hospitalization - You have been diagnosed with sarcopenia (low muscle mass/strength) by your doctor - You are 20 years old or older **You may NOT be eligible if...** - You are unwilling to sign a consent form - You are under 20 years old - You are bedridden or cannot walk due to a physical disability - You have terminal cancer or HIV/AIDS - You have significant leg or body swelling (pitting edema grade +2 or higher) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTSarcojoint®

All participants are administered Sarcojoint® containing leucinine 1 g, arginine 1.5 g, Vitamin D 7.5μg, chondroitin 400 mg, calcium 300 mg, and glucosamine 700 mg per package, and take 1 package twice a day.

BEHAVIORALsupervised exercise

All participants are required to walk 6500 steps every day for 12 weeks, and the data are recorded by Xiaomi-smart-band.


Locations(1)

Taichung Veterans General Hospital

Taichung, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05926713


Related Trials